ALLIED CORP - ALID STOCK NEWS

Allied Corp (OTCQB: ALID) has received clearance from Colombian authorities to export cannabis-based products from its inaugural harvest. This milestone follows the acquisition of Allied Colombia and its licenses in February 2020. Over the past fourteen months, Allied has developed its production center, registered its genetics, and secured sales contracts with international buyers. Only a handful of Colombian companies have received similar export clearance, signifying Allied's competitive position in the market. CEO Calum Hughes highlighted this achievement as evidence of the team's capability to execute their business plan effectively.

Allied Corp (OTCQB: ALID) announced promising production data from its Colombian operations, highlighting a significant increase in production yields and cannabinoid percentages compared to North America. The first harvest yielded 424 grams per square meter, increasing to 905 grams in the latest harvest. Cannabinoid content reached 29.08% THC and 24.64% CBD, with production costs averaging just $0.05 per gram. The company maintains high quality with no pesticide use, adhering to international standards. Weekly rolling harvests enable reliable supply for international markets.

Allied Corp (OTCQB: ALID) has made significant strides in its US operations by signing a 25-year land lease in Las Vegas. The company completed a $3.5 million, 9,000-square-foot GMP-compliant facility for cannabis cultivation and research. Additionally, Allied US Products LLC has secured a Nevada cannabis license, essential due to the state's licensing restrictions. A master services agreement has been established with a licensed operator to manage the facility’s operations. This development aligns with Allied's strategy to create a vertically integrated supply chain for medical cannabis production.

Allied Corp. (OTCQB: ALID) has received approval from the Colombian Institute of Agriculture (ICA) for the cultivation of its 10 proprietary psychoactive cannabis strains. This approval follows a year-long process that included rigorous testing and evaluations. The company aims to broaden its product portfolio and enhance revenue generation. The lab results from these strains indicate higher cannabinoid profiles when cultivated in Colombia compared to North America. Allied's CEO expressed pride in this significant milestone that positions the company for future commercialization opportunities.

Allied Corp. (OTCQB: ALID) has engaged IDR Marketing, Inc. to enhance its public relations and brand presence. IDR will implement strategies to improve Allied's visibility through various channels, including advertising and social media. CEO Calum Hughes emphasizes the need to effectively communicate their story to the investment community. IDR Marketing specializes in supporting small and microcap companies and does not hold any securities of Allied Corp. This collaboration aims to strengthen Allied’s profile in the competitive medical cannabis market.

Allied Corp (OTCQB: ALID) has signed a letter of intent with Fiore Cannabis Ltd. to acquire a US cultivation license in Nevada and lease a 9,000 square foot facility. The facility, valued at $3.5 million, is ready for cannabis cultivation and research, including psilocybin. Allied aims to utilize low-cost Colombian cannabis for US retail through its integrated supply chain. CEO Calum Hughes emphasized the significance of this expansion in anticipation of US cannabis legalization, leveraging existing Colombian production capabilities.

Allied Corp. (OTCQB: ALID) has signed its first monthly recurring purchase order with Mistral Consulting Group, marking a significant milestone in its cannabis product sales. The agreement entails a scaled monthly purchase of extracted cannabis products, starting at 1-5 kgs and potentially increasing to 50 kgs by March 2021. The contract spans 12 months with a 5-year extension option. Allied will ensure compliance with strict quality standards, enhancing investor confidence in its revenue growth capabilities.

Allied Corp. (OTCQB: ALID) announced that its subsidiary, Allied Colombia SAS, received approval from Colombia's Institute of Agriculture (ICA) for the cultivation and commercialization of ten proprietary cannabis strains. This includes nine non-psychoactive and one psychoactive strain, allowing Allied to process and sell its Colombian production. The approval followed a rigorous year-long seed evaluation process, confirming higher cannabinoid profiles in Colombian-grown strains. Allied plans to pursue additional psychoactive strains and aims to generate revenue through product commercialization.

Allied Corp. (OTCQB: ALID) announces a definitive agreement with Reef Drink Company to launch a CBD-infused electrolyte replacement drink called “Tactical Hydration.” This product is part of the Tactical Relief™ brand aimed at veterans and first responders. Allied also introduces a new brand, Equilibrium Bio, with its first product, “Hydration Blast,” targeting athletic consumers. The drinks will feature sodium citrate electrolytes and come in various flavors, with 15,000 sample products ready for wholesale by October 2020.